{"nct_id":"NCT02120417","title":"A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer","status":"TERMINATED","status_verified_date":"2018-01","start_date":"2014-05","start_date_type":"ACTUAL","primary_completion_date":"2016-02","primary_completion_date_type":"ACTUAL","completion_date":"2017-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}